The Department of Translational Hematology & Oncology Research conducts cancer research to develop and make available novel diagnostic tools, targeted therapies and clinical trials for direct use in patient care.
More About UsThe Li Lily Wang lab studies how immune checkpoint proteins regulate anti-tumor immune responses.
Learn MoreThe Yogen Saunthararajah lab studies how to selectively target and eliminate cancer cells without harming healthy cells.
Learn MoreThe Omar Mian lab studies the genetic and epigenetic mechanisms underlying lethal genitourinary cancers.
Learn MoreResearchers used reinforcement learning to design antibiotic regimens to prevent treatment resistance.
Data from thousands of patients with myeloid neoplasms reveals that PHF6 contributes to sex differences, poor prognosis in leukemia patients.
The new Cleveland Clinic-developed model incorporates how evolution contributes to drug effectiveness and dosage.
Exciting investigation and groundbreaking discovery happens every day at Cleveland Clinic. Join our team of expert researchers at the Department of Translational Hematology & Oncology Research.
View Careers